ArticleFrontiers in cell and developmental biology2025

PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation.

Nevena Grdović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.